Home › NDC Lookup › Ingredients › Simethicone › 70677-1078-01
💧image loading
(from DailyMed)

Foster and Thrive infants Gas relief simethicone 20 mg/.3mL Solution/ Drops — NDC 70677-1078-1 (Billing 70677-1078-01)

by Strategic Sourcing Services LLC · 1 BOTTLE, DROPPER in 1 CARTON / 30 mL in 1 BOTTLE, DROPPER

This is a package of Foster and Thrive infants Gas relief simethicone 20 mg/.3mL Solution/ Drops from Strategic Sourcing Services LLC, marketed since Jun 2023 and currently FDA-listed; retail pharmacies pay about $0.1023 per mL (NADAC). It is this product's only package size.

NDC 70677-1078-01
🏷️ FDA NDC (as labeled) 70677-1078-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1078-1
Product NDC 70677-1078
11-digit billing NDC 70677107801
NCPDP billing unit ML — per mL (volume)
UNII 92RU3N3Y1O
Application # M
SPL Set ID 824c9dff-0a26-4710-a25b-39df631d6fa6
Physiologic effect Skin Barrier Activity
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-06-12
Route ORAL
Dosage form SOLUTION/ DROPS
Substance DIMETHICONE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 52200020001810
GCN Seq No 002815
GCN 08260
HICL code 001224
Ingredient (HICL) Simethicone
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4N
Therapeutic class — specific (HIC3) Antiflatulents
AHFS code 56:10.00.00
AHFS class Antiflatulents
FDB label name FT INFT GAS RLF 20 MG/0.3 ML
FDB brand name Infants' Gas Relief
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002815
  • GCN: 08260
  • GPI-14 (Medi-Span): 52200020001810
  • HICL (First Databank): 001224
  • AHFS class code: 56:10.00.00
Why two NDCs? The FDA registers this code as 70677-1078-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1078-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name FT INFT GAS RLF 20 MG/0.3 ML Ingredient Simethicone
📗 Our plain-language guide HelloPharmacist
  • It relieves the discomfort of gas. For adults, that means pressure, bloating and fullness. Infant drops are for baby gas, often caused by swallowed air or certain formulas or foods...
  • Shake the bottle well. Use only the syringe or dropper that came with it. Dispense it slowly toward the inner cheek. You can also mix it with 1 oz. of cool water, formula or anothe...
  • Doses can be repeated as needed after meals and at bedtime. Do not go over 12 doses in a day. Follow your product’s label and your doctor’s advice.
  • If you can, use your child’s weight. If not, use age. Check the chart on your product, and ask me or your doctor if you are unsure.
📖 Read our full Simethicone guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.102 $3.07 / 30 ml
Medicaid paysCMS SDUD · 12 mo $0.2279 $6.84 / 30 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2023 Jan 2026 May 2026 Sep 2026 $0.106 $0.092
▲ Up 11% over the last 13 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70677-1078-01 You're viewing this Main listing 1 BOTTLE, DROPPER in 1 CARTON / 30 mL in 1 BOTTLE, DROPPER 2023-06-12 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Infants 20 mg/.3mL 00536-1303-75 RUGBY 1 bottle $0.102 — Availability likely —
Infant Gas Relief 20 mg/.3mL 46122-0547-03 AMERISOURCEBERGEN 1 bottle $0.102 — Availability likely —
Cardinal Health Infants Gas Relief 20 mg/.3mL 70000-0051-01 CARDINAL 1 bottle $0.102 — Availability likely —
Foster and Thrive infants Gas relief 20 mg/.3mLthis 70677-1078-01 Strategic 1 bottle $0.102 — Availability likely —
SIMETHICONE INFANT Gas Relief Drops 20 mg/.3mL 82568-0017-03 AARNA 1 bottle $0.102 — Availability likely —
Quality Choice Infants Non-staining Gas relief 20 mg/.3mL 83324-0133-01 Chain 1 bottle $0.102 — Availability likely —
Infants Simethicone Drops 20 mg/.3mL 00121-1094-03 PAI 25 syringes — — FDA listed —
Childrens Simethicone Drops 40 mg/.6mL 00121-1095-03 PAI 25 syringes — — FDA listed —
Walgreens Infants Dye Free Gas Relief 20 mg/.3mL 00363-0790-30 WALGREEN 1 bottle — — FDA listed —
SIMETHICONE INFANT Gas Relief Drops 20 mg/.3mL 17856-1017-01 Atlantic 120 syringes — — FDA listed —
SIMETHICONE INFANT Gas Relief Drops 20 mg/.3mL 17856-1018-01 Atlantic 60 syringes — — FDA listed —
TEENY TUMMY Gas Relief Drops 20 mg/.3mL 17856-1141-01 ATLANTIC 120 syringes — — FDA listed —
TEENY TUMMY Gas Relief Drops 20 mg/.3mL 17856-1142-01 ALTANTIC 60 syringes — — FDA listed —
Infants 20 mg/.3mL 17856-1303-01 ATLANTIC 120 syringes — — FDA listed —
QUITA COLICOS Gas RELIEF Drops 20 mg/.3mL 24286-1533-08 DLC 1 bottle — — FDA listed —
Infants Gas Relief Dye Free 20 mg/.3mL 30142-0171-01 THE 1 bottle — — FDA listed —
Infants Gas relief 20 mg/.3mL 41163-0096-09 UNITED 1 bottle — — FDA listed —
Meijer Infants Gas Relief Drops 20 mg/.3mL 41250-0470-01 MEIJER 1 bottle — — FDA listed —
Publix Infants Dye Free Gas Relief 20 mg/.3mL 41415-0709-01 PUBLIX 1 bottle — — FDA listed —
Infants Gas Relief Drops 20 mg/.3mL 49035-0709-01 Wal-Mart 1 bottle — — FDA listed —
Infants Gas Relief Drops 20 mg/.3mL 55910-0790-01 DOLGENCORP 1 bottle — — FDA listed —
Infants Gas Relief 20 mg/.3mL 57896-0798-01 Geri-Care 1 bottle — — FDA listed —
Mylicon Infants Gas Relief Original 20 mg/.3mL 62372-0630-15 Infirst 1 bottle — — FDA listed —
Mylicon Infants Gas Relief Dye Free 20 mg/.3mL 62372-0650-15 Infirst 1 bottle — — FDA listed —
Little Remedies Gas Relief Drops 20 mg/.3mL 63029-0103-01 Medtech 1 bottle — — Discontinued —
Quality Choice Infants Dye Free Gas Relief 20 mg/.3mL 63868-0696-30 CHAIN 1 bottle — — FDA listed —
Best Choice 20 mg/.3mL 63941-0709-01 BEST 1 bottle — — FDA listed —
premier value infants gas relief 20 mg/.3mL 68016-0670-00 Chain 1 bottle — — FDA listed —
Infants Gas Relief Drops 20 mg/.3mL 69618-0059-51 RELIABLE 1 bottle — — FDA listed —
Gas-Aid Drops for infants 20 mg/.3mL 69626-5200-09 Leosons 1 bottle — — FDA listed —
CVS Health Anti gas 20 mg/.3mL 69842-0977-01 CVS 1 bottle — — FDA listed —
CVS Health Infant Gas Relief 20 mg/.3mL 69842-0979-15 CVS 1 bottle — — FDA listed —
TEENY TUMMY Gas Relief Drops 20 mg/.3mL 71399-0041-01 Akron 30 ml — — FDA listed —
simethicone gas relief 20 mg/.3mL 71444-0788-01 MOM 1 bottle — — FDA listed —
Infants Gas Relief 20 mg/.3mL 82179-0007-01 Mollec 1 bottle — — FDA listed —
Quality Choice Infants Gas Relief Dye Free 20 mg/.3mL 83324-0335-01 QUALITY 1 bottle — — FDA listed —
Infants Non-staining Gas relief 20 mg/.3mL 37808-0014-09 H 1 bottle — — FDA listed —
Infants Non staining Gas relief 20 mg/.3mL 72476-0520-09 Retail 1 bottle — — FDA listed —
Infants Gas relief 20 mg/.3mL 36800-0119-09 Topco 1 bottle — — FDA listed —
Infants Gas relief 20 mg/.3mL 69256-0520-09 Harris 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Jun 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 8SKN0B0MIM
    Benzoic acid is a naturally occurring organic acid used as a preservative in medicines and foods. It helps prevent bacterial and fungal growth to extend shelf life and maintain product stability.
  • UNII 6M3P64V0NC
    A fine powder made from magnesium, aluminum, and silicon compounds. It absorbs moisture and helps keep medicine ingredients from clumping or separating, so the product stays stable and flows smoothly during manufacturing.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzoic acid, flavor, magnesium aluminum silicate, purified water, simethicone emulsion, sorbitol, xanthan gum.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
FDA applicationM (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedJun 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 16 words ▾

USE(S) relieves the symptoms of gas frequently caused by air swallowing or certain formulas or foods

⏱️ Dosage and Administration 80 words ▾

DIRECTIONS shake well before using all dosages may be repeated as needed, after meals and at bedtime fill enclosed dropper to recommended dosage level dispense liquid slowly into baby's mouth, toward the inner cheek may mix with 1 oz. of cool water, infant formula or other suitable liquids. clean dropper after each use and close the bottle to maintain child resistance age (yr) weight (lb) dose infants under 2 under 24 0.3 mL children over 2 over 24 0.6 mL

⚠️ Warnings 2 words ▾

WARNINGS .

🧪 Active Ingredient 5 words ▾

ACTIVE INGREDIENT(S) Simethicone 20 mg

🧪 Inactive Ingredients 15 words ▾

INACTIVE INGRADIENTS benzoic acid, flavor, magnesium aluminum silicate, purified water, simethicone emulsion, sorbitol, xanthan gum.

🎯 Purpose 2 words ▾

PURPOSE Antigas

📄 When Using This Product 11 words ▾

WHEN USING THIS PRODUCT do not exceed 12 doses per day

📄 Keep Out of Reach of Children 22 words ▾

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Other Information 6 words ▾

OTHER INFORMATION store at room temperature

📄 Questions or Comments 13 words ▾

QUESTIONS OR COMMENTS? Call 833-358-6431 Monday to Friday 9:00 to 7:00 pm EST

📄 Package Label / Principal Display Panel 60 words ▾

PRINCIPAL DISPLAY PANEL NDC 70677-1078-1 COMPARE TO MYLICON ® NON-STAINING INFANTS' DROPS ACTIVE INGREDIENT* Foster and Thrive TM INFANTS' Gas Relief Drops Simethicone 20 mg ANTIGAS Relief of gas symptoms: Pressure Bloating Non-staining Formula Alcohol Free Saccharin Free 1 FL. OZ. (30 mL) 100 Doses F and T Gas Relief drops 520 F and T Gas Relief Drops- Label -520

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
2.8K
Units reimbursed last 4 qtrs
123.4K
Gross reimbursed last 4 qtrs
$28.1K
Avg / prescription
$9.88
Avg / unit
$0.2279
Latest quarter Q1 2026
1.1KRx
Medicaid pays / mL
$0.2279
gross reimbursed
vs
NADAC / mL
$0.1023
acquisition cost
=
Spread
+$0.1256
+123% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
48% FFS 52% MCO
Fee-for-service · 1,378 Rx Managed care · 1,469 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 12,105 units · 211 per 100k residents MN Wisconsin: 11,940 units · 202 per 100k residents WI Michigan: 18,958 units · 189 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: 330 units · 23.5 per 100k residents NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 9,510 units · 80.7 per 100k residents OH Pennsylvania: 5,226 units · 40.3 per 100k residents PA New Jersey: 6,532 units · 70.3 per 100k residents NJ Massachusetts: 4,629 units · 66.1 per 100k residents MA California: 35,375 units · 90.8 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 5,220 units · 264 per 100k residents NE Missouri: no data reported MO Kentucky: 3,429 units · 75.8 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 2,430 units · 32.7 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 1,530 units · 28.5 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: 780 units · 54.4 per 100k residents HI Texas: 5,400 units · 17.7 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
17.7264
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Nebraska 264 /100k
2 Minnesota 211 /100k
3 Wisconsin 202 /100k
4 Michigan 189 /100k
5 California 90.8 /100k
6 Ohio 80.7 /100k
7 Kentucky 75.8 /100k
8 New Jersey 70.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Foster and Thrive infants Gas relief (this brand).

Top reported reactions

Nausea106
Fatigue83
Diarrhoea79
Vomiting70
Abdominal Pain67
Dyspnoea66
Pain58

Age at onset

Neonate2
Infant1
Child9
Adolescent6
Adult27
Elderly11

Reporter sex

1,061 reports
Male · 48%
Female · 51%
Unknown · 0%

Serious outcomes

Death149
Life-threatening68
Disabling29
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 9 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 70677-1077-01 · Strategic 70677-1079-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.